Characterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infants

HONG-YUAN HSUHUEY-LING CHENChiang, Cheng-LunCheng-LunChiangLai, Ming-WeiMing-WeiLaiMu, Shu-ChiShu-ChiMuWen, Wan-HsinWan-HsinWenCheng, Shao-WenShao-WenChengHu, Jen-JanJen-JanHuKAI-CHI CHANGCHIEN-NAN LEECHUN-JEN LIUJIA-FENG WUYEN-HSUAN NIMEI-HWEI CHANG2023-04-202023-04-202023-02-081058-4838https://scholars.lib.ntu.edu.tw/handle/123456789/630332Maternal tenofovir disoproxil fumarate (TDF) therapy during late pregnancy can reduce mother-to-infant transmission of hepatitis B virus (HBV). We investigated HBV mutations associated with maternal TDF therapy and their role in infant immunonophylaxis failure (IPF).enHBV carriers; HBV genetic variation; antiviral therapy; immunoprophylaxis failure infants; pregnant womenCharacterization of Hepatitis B Virus in Tenofovir-Treated and Untreated Chronically Infected Mothers and Their Immunoprophylaxis Failure Infantsjournal article10.1093/cid/ciac539357892612-s2.0-85147783406WOS:000840103100001https://api.elsevier.com/content/abstract/scopus_id/85147783406